Stocks
4D Molecular Therapeutics, Inc.FDMT
NASDAQHealthcareBiotechnology$10.80
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted gene therapies for rare and large-market diseases, with a pipeline centered on its proprietary AAV vector platform. Investors track FDMT for its lead candidates in ophthalmology and pulmonology, including ongoing Phase 3 trials for wet age-related macular degeneration.
52W Range: $6.96-$16.93
Congressional Interest in 4D Molecular Therapeutics, Inc. (FDMT)
No congressional trades have been disclosed for 4D Molecular Therapeutics, Inc. (FDMT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading FDMT?
No congressional trades found for this stock.